Developing as a promising development in the struggle against obesity, Retatrutide is capturing considerable interest . This treatment combines the action of two established GLP-1 receptor agonists, liraglutide, with an additional glucose-dependent peptide component. Early study findings have indicated substantial weight decrease in individuals wi